For laboratory research use only — not for human consumption
For laboratory research use only — not for human consumption
Comparison
A neutral, structural comparison of BPC-157 and MOTS-c as research compounds — written for researchers evaluating the two. It describes structure and research context only; it makes no human-use, dosing, or therapeutic claim. Both are supplied for in-vitro laboratory research use only.
| BPC-157 | MOTS-c | |
|---|---|---|
| Class | Synthetic pentadecapeptide | Mitochondrial-derived peptide |
| Research area | Peptide & tissue-signalling research | Mitochondrial-peptide research |
| CAS number | 137525-51-0 | 1627580-64-6 |
| Molecular formula | C62H98N16O22 | C101H152N28O22S2 |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg |
| HPLC purity | 98.67% | 99% |
BPC-157 is a synthetic pentadecapeptide (a 15-amino-acid sequence) widely used as a reference compound in laboratory peptide research. It is one of the most frequently studied research peptides and appears often alongside TB-500 in comparative literature.
MOTS-c is a mitochondrial-derived peptide (encoded within the mitochondrial genome) studied in laboratory research into mitochondrial and metabolic-signalling pathways. As one of the better-characterised mitochondrial-derived peptides, it is a frequent reference compound in this emerging research area.
Both compounds are supplied strictly for in-vitro laboratory research use only. Not for human or veterinary use. This comparison is structural and contextual and does not constitute advice on use.
